3352 Surgical Adjuvant of Immunomodulatory Gene Circuits for Treatment of Glioblastoma

OBJECTIVES/SPECIFIC AIMS: Glioblastoma (GBM) is a brain cancer with a devastatingly short overall survival of under two years. The poor prognosis of GBM is largely due to cell invasion and maintenance of cancer initiating cells that evade the brain’s innate and adaptive immune responses which enable...

Descripción completa

Detalles Bibliográficos
Autores principales: Spatz, Jordan Matthew, Wu, Ming Ru, Weisinger, Karen, Lu, Tim, Aghi, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Translational Science, Policy, & Health Outcomes Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799755/
http://dx.doi.org/10.1017/cts.2019.355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799755/
http://dx.doi.org/10.1017/cts.2019.355

Ejemplares similares